2-May-2024
No headlines found.
INOVIO Reports Inducement Grants Under Inducement Plan
PRNewswire (Wed, 1-May 8:00 AM ET)
INOVIO to Participate in Upcoming Investor Conferences in May
PRNewswire (Mon, 29-Apr 8:00 AM ET)
INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
PRNewswire (Mon, 29-Apr 8:00 AM ET)
PRNewswire (Mon, 15-Apr 6:39 PM ET)
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
PRNewswire (Tue, 26-Mar 6:28 PM ET)
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
PRNewswire (Wed, 6-Mar 4:05 PM ET)
PRNewswire (Wed, 6-Mar 7:00 AM ET)
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
PRNewswire (Wed, 21-Feb 8:00 AM ET)
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PRNewswire (Wed, 7-Feb 11:46 AM ET)
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Inovio Pharmaceuticals trades on the NASDAQ stock market under the symbol INO.
As of May 2, 2024, INO stock price climbed to $12.01 with 258,487 million shares trading.
INO has a beta of 1.70, meaning it tends to be more sensitive to market movements. INO has a correlation of 0.05 to the broad based SPY ETF.
INO has a market cap of $311.14 million. This is considered a Small Cap stock.
Last quarter Inovio Pharmaceuticals reported $103,000 in Revenue and -$1.10 earnings per share. This fell short of revenue expectation by $-237,000 and exceeded earnings estimates by $.17.
In the last 3 years, INO stock traded as high as $123.96 and as low as $3.89.
The top ETF exchange traded funds that INO belongs to (by Net Assets): VTI, VXF, VHT, DFAC, AVSC.
INO has outperformed the market in the last year with a price return of +31.4% while the SPY ETF gained +23.2%. INO has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +126.2% and +8.5%, respectively, while the SPY returned +3.6% and +0.9%, respectively.
INO support price is $10.86 and resistance is $12.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INO stock will trade within this expected range on the day.